Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Cattran

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of the American Society of Nephrology : JASN|January 23, 2003
Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosisDaniel Cattran, Tuhina Neogi, Ram Sharma, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2008
Remission of resistant MPGN type I with mycophenolate mofetil and steroidsSudarsana De, Dana Al-Nabhani, Paul Thorner, et al.
Transplantation|June 28, 2003
Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipientsEdward Cole, Nava Maham, Carl Cardella, et al.
Kidney International Reports|October 26, 2020
Why Target the Gut to Treat IgA Nephropathy?Jonathan Barratt, Brad H Rovin, Daniel Cattran, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 7, 2009
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug AdministrationAndrew S Levey, Daniel Cattran, Aaron Friedman, et al.
Clinical Transplantation|September 12, 2007
Renal transplant outcome in high-cardiovascular risk recipientsTarun K Jeloka, Heather Ross, Robert Smith, et al.
Kidney International Reports|May 5, 2018
Long-term Eculizumab Therapy in a Child With Refractory Immune Complex-Mediated Membranoproliferative GlomerulonephritisRahul Chanchlani, Paul Thorner, Seetha Radhakrishnan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2014
A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathyMichelle A Hladunewich, Daniel Cattran, Laurence H Beck, et al.
Journal of the American Society of Nephrology : JASN|February 14, 2015
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA StudyVladimir Tesar, Stéphan Troyanov, Shubha Bellur, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosisNing He, Alireza Zahirieh, Yan Mei, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of the American Society of Nephrology : JASN|January 23, 2003
Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosisDaniel Cattran, Tuhina Neogi, Ram Sharma, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2008
Remission of resistant MPGN type I with mycophenolate mofetil and steroidsSudarsana De, Dana Al-Nabhani, Paul Thorner, et al.
Transplantation|June 28, 2003
Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipientsEdward Cole, Nava Maham, Carl Cardella, et al.
Kidney International Reports|October 26, 2020
Why Target the Gut to Treat IgA Nephropathy?Jonathan Barratt, Brad H Rovin, Daniel Cattran, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 7, 2009
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug AdministrationAndrew S Levey, Daniel Cattran, Aaron Friedman, et al.
Clinical Transplantation|September 12, 2007
Renal transplant outcome in high-cardiovascular risk recipientsTarun K Jeloka, Heather Ross, Robert Smith, et al.
Kidney International Reports|May 5, 2018
Long-term Eculizumab Therapy in a Child With Refractory Immune Complex-Mediated Membranoproliferative GlomerulonephritisRahul Chanchlani, Paul Thorner, Seetha Radhakrishnan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2014
A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathyMichelle A Hladunewich, Daniel Cattran, Laurence H Beck, et al.
Journal of the American Society of Nephrology : JASN|February 14, 2015
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA StudyVladimir Tesar, Stéphan Troyanov, Shubha Bellur, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosisNing He, Alireza Zahirieh, Yan Mei, et al.
Pageof 6